FDA approved expanded pediatric age indication for Fluarix Quadrivalent influenza vaccine
On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
-
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Influenza | U.S. Congress | Vaccine | Veterinary
Experts decried lack of flu pandemic readiness, commitment
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
-
NIH expanded license agreement with Medigen Vaccines Biologics for Dengue vaccine from 17 to 26 countries
On Sept. 18, 2017, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
-
PATH announced a $120 million grant from the Bill & Melinda Gates Foundation
On Sept. 6, 2017, PATH announced it has received a $120 million grant from the Bill & Melinda…
-
Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes
On Aug. 28, 2017, a team of researchers led by the Yale School of Public Health announced they…
-
Biotechnology | CDC | Vaccine
AAP issued policy stating that newborns should routinely receive hepatitis B vaccine within 24 hours of birth
On Aug. 28, 2017, the American Academy of Pediatrics (AAP) issued policy stating that newborns should routinely receive…
-
CDC published ACIP 2017-18 influenza vaccination recommendations
On Aug. 25, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
-
Canadian researchers reconstituted an extinct poxvirus using mail-order DNA
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
-
CDC and FDA announced new Vaccine Adverse Event Reporting website and reporting form
On Jun. 30, 2017, the U.S. Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug…
-
Biotechnology | FDA | Therapeutics | Vaccine
The FDA unveiled a strategic plan to completely eliminate the agency’s existing orphan designation backlog
On Jun. 29, 2017, the U.S. Food and Drug Administration unveiled a strategic plan to completely eliminate the…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | NIH | Non-Profit Research | U.S. Congress | Vaccine | Veterinary
HHS Influenza Pandemic Planning Update was published
On Jun. 15, 2017, the U.S. Department of Health and Human Services (HHS) published the nations’s updated Pandemic…
-
Biotechnology | CDC | Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
CDC published ACIP’s updated recommendations on use of Trumenba meningococcal serogroup B vaccine
On May 19, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Biotechnology | Disease | Infectious Disease | Influenza | Non-Profit Research | Therapeutics | Vaccine
CDC updated guidelines for use of non-pharmaceutical measures to help prevent spread of pandemic influenza
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
-
CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
-
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
-
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Medigen Vaccines Biologics teamed with U.S. CDC to develop VLP vaccine for Dengue disease
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
-
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
-
Biotechnology | CDC | Disease | HIV | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of meningococcal conjugate vaccines in HIV-infected persons
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
-
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
-
PAHO/WHO announced measles elimination in the Americas
On Sept. 27, 2016, the Region of the Americas was the first in the world to have eliminated…
-
Arbutus’ CSO, Dr. Michael J Sofia, awarded Lasker-DeBakey Clinical Medical Research Award
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
-
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
-
Biotechnology | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine
AAP released new policy statement that urged states to eliminate all non-medical exemptions to vaccine requirements
On Aug. 29, 2016, the American Academy of Pediatrics (AAP) released new policy statement that urged states to…
-
CDC published 2016-17 influenza vaccination recommendations
On Aug. 26, 2016, the U.S. Centers for Disease Control and Prevention (CDC) published 2016-17 influenza vaccination recommendations….
-
Siteman Cancer Center received a $10.4 million grant from the NCI
On Aug. 15, 2016, Siteman Cancer Center received a $10.4 million five-year grant to Washington University researchers and…
-
FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 years
On Jul. 12, 2016, Pfizer announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S….
-
ACIP voted that live attenuated influenza vaccine (LAIV) should not be used during the 2016-2017 flu season
On Jun. 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
-
Biotechnology | FDA | Vaccine
FDA approved Vaxchora for the prevention of cholera
On Jun. 12, 2016, the U.S. Food and Drug Administration (FDA) approved Vaxchora, a vaccine for the prevention…
-
Agriculture | Biotechnology | Infectious Disease | Medicine | Pharmaceutical | Therapeutics | Vaccine
Texas A&M and iBio execute development agreement for plant-produced pharmaceuticals
On Jun. 7, 2016, the Texas A&M University System (TAMUS) announced it had entered into a joint development…
